Skip to main content

July 7, 2010

UNC Team Finds New Target for Treatment of Advanced Prostate Cancer

CHAPEL HILL, NC – In its early stages, prostate cancer requires androgens (hormones that promote the development and maintenance of male sex characteristics) for growth, and current first-line therapies target the receptor for these hormones to slow cancer’s development and spread. However, advanced prostate cancers are often androgen-independent, meaning that androgen-blocking therapies are ineffective. Scientists …